At the last check on Friday, Cogent Biosciences Inc.’s (NASDAQ:COGT) stock was up $0.73, moving up 5.97 percent to $12.94. The average number of shares traded per day over the past five days has been 411,867 shares. 3 times new highs have been achieved over the past 5 days, with a $0.78 gain in that time frame. In the last twenty days, the average volume was 708,592, while in the previous 50 days, it was 633,325.
Since last month, COGT stock rose 6.93%. Shares of the company fell to $10.37 on 08/08/23, the lowest level in the past month. A 52-week high of $18.07 was reached on 02/03/23 after having rallying from a 52-week low of $9.65. Since the beginning of this year, COGT’s stock price has risen by 11.93% or $1.37, and marked a new high 12 times. However, the stock has declined by -28.40% since its 52-week high.
Top 5 AI Stocks to Buy for 2023
The artificial intelligence (AI) revolution is already here. And it's about to change everything we know about everything.
According to Grand View Research, the global AI boom could grow from about $137 billion in 2022 to more than $1.81 trillion by 2030. And investors like you always want to get in on the hottest stocks of tomorrow. Here are five of the best ways to profit from the AI boom.
Click Here to Download the FREE Report.
Sponsored
COGT stock investors should be aware that Cogent Biosciences Inc. (COGT) stock had its last reported insider trading activity 84 days ago on Jun 09. Fairmount Funds Management LLC, the 10% Owner of the company, purchased of 800,000 shares for $12.00 on Jun 09. It resulted in a $9,600,000 investment by the insider.
Financial Health
In the three months ended June 29, Cogent Biosciences Inc.’s quick ratio stood at 13.00, while its current ratio was 13.00, showing that the company is able to pay off its debt. Based on annual data, COGT earned $147.84 million in gross profit.
While analysts expected Cogent Biosciences Inc. to report -$0.54 quarterly earnings, the actual figure was -$0.59 per share, beating the consensus estimate by -9.30%. The liabilities of Cogent Biosciences Inc. were 43.94 million at the end of its most recent quarter ended June 29, and its total debt was $19.36 million. The value of shareholders’ equity is $85.47 million.
Technical Picture
This quick technical analysis looks at Cogent Biosciences Inc.’s (COGT) price momentum. With a historical volatility rate of 27.69%, the RSI 9-day stood at 72.33% on 31 August.
With respect to its five-day moving average, the current Cogent Biosciences Inc. price is up by +6.42% percent or $0.78. At present, COGT shares trade +12.34% above its 20-day simple moving average and +23.73% percent above its 100-day simple moving average. However, the stock is currently trading approximately +7.84% above its SMA50 and +6.60% above its SMA200.
Stochastic coefficient K was 83.67% and Stochastic coefficient D was 81.35%, while ATR was 0.46. Given the Stochastic reading of 89.06% for the 14-day period, the RSI (14) reading has been calculated as 63.34%. As of today, the MACD Oscillator reading stands at 0.22, while the 14-day reading stands at 0.36.
